Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 201 - 220 of 494 trials
Title Investigatorsort icon Disease(s)
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Phase II Study of Early Post-Operative Abdominal Chemotherapy versus Heated Abdominal Chemotherapy for Cancers of the Appendix, Colon, or Rectum that Have Spread to the Abdominal Lining
[Protocol 12-289]
Nash, Garrett
  • Colorectal Cancer
A Phase II Study of MPDL3280A Alone or with Bevacizumab versus Sunitinib Alone in Patients with Previously Untreated Advanced Renal Cell Cancer
[Protocol 13-212]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of Cabozantinib versus Everolimus in Patients with Progressive Kidney Cancer
[Protocol 13-124]
Motzer, Robert
  • Kidney Cancer
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 12-282]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase IB Study of MK-3475 in Patients with Myelodysplastic Syndromes and Lymphoma
Relapsed/Refractory
[Protocol 13-220]
Moskowitz, Craig
  • Hematology
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Pilot Study of Brentuximab Vedotin with Chemotherapy and Radiation Therapy in Early-Stage Poor-Risk Newly Diagnosed Hodgkin Lymphoma
[Protocol 13-034]
Moskowitz, Craig
  • Lymphoma
    • Hodgkin's Disease
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-142]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
A Phase I Study of Brentuximab Vedotin plus Temsirolimus in Relapsed and Refractory Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 13-044]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007]
Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
[18F]-Deoxy-D-Glucose (FDG) and [18F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer
[Protocol 00-095]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
    • Rising PSA After Primary Therapy
A Phase III Study of Enzalutamide Alone or with Abiraterone and Prednisone for Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-247]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc
  • Head & Neck Cancer
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria
  • Kidney Cancer
A Phase I Study of LJM716, BYL719, and Trastuzumab in Women with Metastatic HER2-Positive Breast Cancer
[Protocol 14-057]
Modi, Shanu
  • Breast Cancer
A Phase I Study of SGN-LIV1A in Women with Metastatic Breast Cancer
[Protocol 14-013]
Modi, Shanu
  • Breast Cancer
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase IB Study of LEE011 and Exemestane with and without Everolimus in Women with Locally Advanced or Metastatic Breast Cancer
[Protocol 13-179]
Modi, Shanu
  • Breast Cancer
A Phase I Study of Ganetespib with Paclitaxel and Trastuzumab in Women with Metastatic Breast Cancer
[Protocol 13-168]
Modi, Shanu
  • Breast Cancer
A Phase II Study of BYL719 plus AMG 479 (Ganitumab) in Patients with Advanced Ovarian Cancer or Hormone Receptor-Positive Breast Cancer
[Protocol 13-251]
Modi, Shanu
  • Breast Cancer
  • Ovarian Cancer
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma